April 14, 2021 -- Gene Schaefer, ScD, has joined the U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as senior fellow, effective April 5.
Gene Schaefer, ScD, has joined NIIMBL as senior fellow. Image courtesy of NIIMBL.
Prior to joining NIIMBL, Schaefer worked at Johnson & Johnson as senior director of active pharmaceutical ingredient (API) large-molecule pharmaceutical development and manufacturing sciences. In over 35 years of experience in the biopharmaceutical field, Schaefer has worked at Bristol-Myers Squibb, Schering-Plough, and Genzyme.
As senior fellow, Schaefer will lead the organization's N-monoclonal antibody (mAb) case study and play an important role in the process intensification program and the regulatory considerations committee.
NIIMBL is a public-private partnership with the mission of accelerating biopharmaceutical innovation, supporting the development of standards that enable more efficient and rapid manufacturing capabilities, and educating and training a world-leading biopharmaceutical manufacturing workforce in the U.S.
Copyright © 2021 scienceboard.net